Thus, these results suggested that TMZ-induced cytotoxicity combined with BA-mediated inhibition of Sp1 and Sp1 downstream cellular stress responses could be a potential therapeutic strategy for GBM. This evidence concerns the gene SP1 and glioblastoma.